PACB
Pacific Biosciences of California
2.50$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +114.5% | +2.7% | +18.9% | +12.7% | -32.0% | +3,305.9% | -98.8% | -4.0% | +5.7% | -12.6% | +111.3% | – | |
| – | -15.8% | +17.7% | -11.8% | +6.0% | -12.2% | -42.6% | +29.3% | -7.7% | -12.7% | -53.5% | +207.7% | – | |
| – | – | – | – | – | – | -128.5% | – | – | +133.6% | -57.7% | -189.0% | – | |
| – | +143.9% | +91.7% | -61.9% | -46.8% | +105.5% | +295.1% | -91.4% | -84.4% | +901.2% | +253.4% | +51.1% | – | |
| – | -127.5% | -48.7% | – | -70.0% | +152.5% | -22.3% | -44.1% | -25.2% | +37.7% | +37.8% | +111.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10,348.4% | – | -102.3% | – | -6,282.3% | – | -100.0% | – | -333.4% | – | +17.7% | – | |
| – | -216.7% | – | – | -192.5% | – | – | -230.5% | – | +318.3% | -206.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.